In acute myeloid leukaemia (AML), the CtBP complex transcriptionally represses MHC‐II genes, while the E3 ubiquitin ligase complex component FBXO11 promotes degradation of CIITA. This evidence concerns the gene FBXO11 and acute myeloid leukemia.